VRK1 promotes cisplatin resistance by up-regulating c-MYC via c-Jun activation and serves as a therapeutic target in esophageal squamous cell carcinoma.
about
VRK1 promotes cisplatin resistance by up-regulating c-MYC via c-Jun activation and serves as a therapeutic target in esophageal squamous cell carcinoma.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
VRK1 promotes cisplatin resist ...... ageal squamous cell carcinoma.
@en
VRK1 promotes cisplatin resist ...... ageal squamous cell carcinoma.
@nl
type
label
VRK1 promotes cisplatin resist ...... ageal squamous cell carcinoma.
@en
VRK1 promotes cisplatin resist ...... ageal squamous cell carcinoma.
@nl
prefLabel
VRK1 promotes cisplatin resist ...... ageal squamous cell carcinoma.
@en
VRK1 promotes cisplatin resist ...... ageal squamous cell carcinoma.
@nl
P2093
P2860
P356
P1433
P1476
VRK1 promotes cisplatin resist ...... ageal squamous cell carcinoma.
@en
P2093
Liang Qiao
Xue-Qing Wang
Zhao-Hua Xiao
Zhen-Chuan Liu
P2860
P304
65642-65658
P356
10.18632/ONCOTARGET.20020
P407
P577
2017-08-07T00:00:00Z